Navigation Links
Some Kids Respond Better to ADHD Drug Than Others
Date:10/23/2011

FRIDAY, Oct. 21 (HealthDay News) -- Children with specific gene variants respond better to the drug methylphenidate (Ritalin, Concerta), which is widely used to treat attention-deficit hyperactivity disorder (ADHD), a new study says.

The finding could help improve treatment of ADHD, according to the Cincinnati Children's Hospital Medical Center researchers.

"Physicians don't have a good way of predicting who will experience great improvement in ADHD symptoms with a particular medication, so currently we use a trial-and-error approach. Unfortunately, as a result, finding an effective treatment can take a long time," lead investigator Dr. Tanya Froehlich, a physician in the division of developmental and behavioral pediatrics, said in a medical center news release.

"With more information about genes that may be involved in ADHD medication response, we may be able to predict treatment course, tailor our approach to each child, and improve symptom response while decreasing health care costs," she said.

The researchers tested 89 children aged 7 to 11 with ADHD and found that those with specific variants of the dopamine transporter (DAT) and dopamine receptor D4 (DRD4) genes showed greater improvement in hyperactivity and impulsivity after taking methylphenidate than those without the gene variants.

Specifically, children with the DAT 10-repeat variant and the DRD4 gene 4-repeat showed more response to methylphenidate than those without the variants. A repeat is a short nucleotide coding sequence in a gene that's repeated.

The study was published Oct. 21 in the Journal of the American Academy of Child and Adolescent Psychiatry.

Further research in a larger number of patients is needed to confirm these findings and their clinical significance, the researchers said.

More information

The U.S. National Institute of Mental Health has more about attention deficit hyperactivity disorder.

-- Robert Preidt

SOURCE: Cincinnati Children's Hospital Medical Center, news release, Oct. 17, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. For Valentine's Day, Lifestyle Correspondent and Her Two Sets of Twins Show a Little Love Where Its Needed the Most
2. FriendsofWater.com Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
3. American Red Cross Responds Internationally and at Home to Chile Quake
4. AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
5. AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
6. Airway Injury Plaguing 9/11 First Responders
7. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
8. Tumors may respond to extreme and moderate heat
9. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
10. Many WTC Responders Show Signs of Heart Trouble
11. Astellas Responds to OSI Pharmaceuticals Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. ... of comments on social media that offer a rare glimpse into the mind of ... authority and New York Times bestselling author, has described people with ADHD as having ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann ... basketball coach who needs treatment for a brain tumor. , Jason Bauer and ...
(Date:12/7/2016)... ... 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering ... is launching a charity drive to raise funds that will benefit the Marine Corps ... marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is ... Awards under the Best New Product Launch category. Gensuite’s entry on their EZ ... , BOC Global Events & Training Group is a professional event and training ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... Dec. 6, 2016   Sienna Biopharmaceuticals, ... dermatology and aesthetics company, today announced it ... specialty pharmaceutical company focused on developing first-in-class ... including psoriasis, atopic dermatitis and pruritus (itch). ... will make an undisclosed upfront payment in ...
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
Breaking Medicine Technology: